|
ZNF597 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.024800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.339200E-01 |
| Normal-vs-Stage2 |
1.552250E-01 |
| Normal-vs-Stage3 |
1.172170E-01 |
| Normal-vs-Stage4 |
5.021400E-01 |
| Stage1-vs-Stage2 |
3.331400E-01 |
| Stage1-vs-Stage3 |
3.208600E-01 |
| Stage1-vs-Stage4 |
6.876200E-01 |
| Stage2-vs-Stage3 |
8.589800E-01 |
| Stage2-vs-Stage4 |
9.023600E-01 |
| Stage3-vs-Stage4 |
8.089800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.980000E-01 |
| Normal-vs-AfricanAmerican |
3.854300E-02 |
| Normal-vs-Asian |
5.980800E-03 |
| Caucasian-vs-AfricanAmerican |
3.545500E-02 |
| Caucasian-vs-Asian |
2.093800E-02 |
| AfricanAmerican-vs-Asian |
3.014600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.070600E-01 |
| Normal-vs-Female |
5.536600E-01 |
| Male-vs-Female |
1.991830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.542840E-01 |
| Normal-vs-Extreme_Weight |
3.276000E-02 |
| Normal-vs-Obese |
3.210200E-01 |
| Normal-vs-Extreme_Obese |
3.907400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.468800E-01 |
| Normal_Weight-vs-Obese |
5.307600E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.310400E-01 |
| Extreme_Weight-vs-Obese |
1.116310E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.892200E-01 |
| Obese-vs-Extreme_Obese |
2.346000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.870200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.484400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.627200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.118000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.218000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.377800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.379000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.305400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.438800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.536600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.631400E-01 |
| Normal-VS-Type2 PRCC |
1.232460E-02 |
| Normal-VS-KIRP CIMP |
6.625800E-01 |
| Normal-VS-Unclassified PRCC |
2.124200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.445840E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.685000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.416410E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.028590E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.412320E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.213800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.207600E-02 |
| Normal-vs-N1 |
4.973200E-01 |
| Normal-vs-N2 |
1.037360E-03 |
| N0-vs-N1 |
4.377600E-02 |
| N0-vs-N2 |
1.860180E-01 |
| N1-vs-N2 |
3.057600E-02 |
|
|
